Precipio, Inc. PRPO · Stock Open Precipio, Inc. in new tab
Precipio, Inc. Analysis (PRPO)
Is Precipio, Inc. a good investment? Precipio, Inc. (PRPO) is currently trading at 23.49 USD.
Earnings Schedule: Precipio, Inc. is expected to release its next earnings report on July 30, 2026. The market consensus estimate for Forward EPS is 0.39.
Investor FAQ
Does Precipio, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Precipio, Inc.?
Precipio, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of -0.45.
Company Profile
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
| Split Date | Split Ratio to 1 |
|---|---|
| April 29, 2019 | 0.070000 |
| Sept. 22, 2023 | 0.050000 |
Community Discussion